*  Progenitor Cell Therapy Continues Expansion | WebWire
Progenitor Cell Therapy, LLC (PCT), a leading full service provider for the contr... ... Cell Therapy Manufacturing Capacity Increased in Mountain View, California., , , , HACKENSACK, New Jersey-(June 26, 2006)- ... About Progenitor Cell Therapy, LLC. Progenitor Cell Therapy is a client-based cell therapy services company that supports the ... tissue collection, processing, and storage, product manufacturing, distribution and transportation. For more information, visit ...
  https://www.webwire.com/ViewPressRel.asp?aId=15741
*  Mesenchymal Stem Cell-Based HLA-Independent Cell Therapy for Tissue Engineering of Bone and Cartilage | BenthamScience
Current Stem Cell Research & Therapy. Title: Mesenchymal Stem Cell-Based HLA-Independent Cell Therapy for Tissue Engineering of ... Mesenchymal Stem Cell-Based HLA-Independent Cell Therapy for Tissue Engineering of Bone and Cartilage. Author(s): Philipp ... Keywords: Mesenchymal Stem Cells, HLA-antigen, Tissue Engineering, bone regeneration, cartilage repair ... Keywords:Mesenchymal Stem Cells, HLA-antigen, Tissue Engineering, bone regeneration, cartilage repair ...
  http://www.eurekaselect.com/56675/article
*  Upstream Single-Use Technologies Archives - Page 4 of 8 - BioProcess InternationalBioProcess International | Page 4
Standards for Ancillary Materials Used in Cell- and Tissue-Based Therapies. by Fouad Atouf, PhD, Nicole M. Provost, PhD and ... Cell- and tissue-based therapies are being used increasingly to treat many diseases for which currently no other adequate ... or injured cells, tissues, or organs. Cells or tissues might be unmanipulated, or their biological characteristics can be ... Examples of cell therapies range from traditional blood transfusions to recent approaches… ...
  http://www.bioprocessintl.com/category/upstream-processing/upstream-single-use-technologies/page/4/
*  Defining the cellular environment in the organ of Corti following extensive hair cell loss: a basis for future sensory cell...
... the sensory epithelium repairs to close the lesions but no new hair cells arise and hearing impairment ensues. For any cell ... Following the loss of hair cells from the mammalian cochlea, ... Cell Differentiation. Cell- and Tissue-Based Therapy / methods ... inner hair cell; Dc = Deiters' cell, ip = inner pillar cell, op = outer pillar cell, Hc = Hensen's cell, Cc = Claudius cell, Bc ... cells in the repaired organ of Corti following hair cell loss may be a consideration for the use of stem cell-based therapies ...
  http://www.biomedsearch.com/nih/Defining-Cellular-Environment-in-Organ/22299045.html
*  Press Releases/Statements
ISSCR Applauds the FDA Announcement of New Guidelines for Cellular Therapies and Cell-based Tissue Products The ISSCR commends ... European Society of Gene and Cell Therapy & ISSCR to Present Latest in Stem Cell Research, Gene Editing and Gene Therapy 18-21 ... The ISSCR opposes the REGROW Act, which would allow certain cell and tissue-based therapeutics to be marketed without first ... ISSCR Comments Before FDA Panel on Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue- ...
  http://www.isscr.org/professional-resources/news-publicationsss/isscr-news-articles/article-listing/-in-category/categories/press-releases-statements
*  OCT4 Remodels the Phenotype and Promotes Angiogenesis of HUVECs by Changing the Gene Expression Profile
Regenerative cell and tissue-based therapies for pulmonary arterial hypertension. Canadian Journal of Cardiology. 2014;30:1350- ... Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle-like cells and ... Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol ... Studies have demonstrated that endothelial cells (ECs) and smooth muscle cells (SMCs) are both separate cell lineages derived ...
  http://www.medsci.org/v13p0386.htm
*  Policy News
ISSCR Applauds the FDA Announcement of New Guidelines for Cellular Therapies and Cell-based Tissue Products The ISSCR commends ... The ISSCR opposes the REGROW Act, which would allow certain cell and tissue-based therapeutics to be marketed without first ... ISSCR Comments Before FDA Panel on Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue- ... than minimal manipulation of a patient's cells and place strict limitations on the direct advertisement of cell-based therapies ...
  http://www.isscr.org/professional-resources/news-publicationsss/newsletter/policy-news
*  Biblio | StemBook
Scaffolds and Cell-Based Tissue Engineering for Blood Vessel Therapy.Cells Tissues Organs.*PubMed ... Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms.Bone ... Yechikov, S., Copaciu, R., Gluck, J.M., Deng, W., Chiamvimonvat, N., Chan, J.W., and Lieu, D.K. (2016). Same-Single-Cell ... Syed, Y.Ahmed, Abdulla, S.Ali, and Kotter, M.R.N. (2017). Studying the Effects of Semaphorins on Oligodendrocyte Lineage Cells. ...
  http://www.stembook.org/biblio?f%5Btg%5D=S
*  Food and Drug Administration - Wikipedia
These include blood and blood products, vaccines, allergenics, cell and tissue-based products, and gene therapy products. New ... Districts are based roughly on the geographic divisions of the federal court system. Each district comprises a main district ... The most rigorous requirements apply to new molecular entities: drugs that are not based on existing medications. New drugs ... This guidance distinguishes the apps subjected to regulation based on the marketing claims of the apps. Incorporation of the ...
  https://en.wikipedia.org/wiki/Food_and_Drug_Administration
*  Joao Lima - Research Output - Johns Hopkins University
Cell- and Tissue-Based Therapy Anatomy Skeletal Muscle Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic ... The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" ( ... Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial ( ... Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema. Doyle, M. F., Tracy, R. P., Parikh, M. A ...
  https://jhu.pure.elsevier.com/en/persons/joao-lima/publications/?type=%2Fdk%2Fatira%2Fpure%2Fresearchoutput%2Fresearchoutputtypes%2Fcontributiontojournal%2Farticle
*  Abstract 12299: Rejuvenation of the Bone Marrow-Derived Cardiac Resident Sca-1+ Stem Cell Subset Improved Healing of the Aged...
Signaling Mechanisms and Drug DiscoverySession Title: Cell and Tissue Engineering Based Therapies ... Quantification by flow cytometry of heart tissue revealed: 1) the Sca-1+ chimeras had more BM-derived cells that co-expressed ... young donor BM cells using magnetic cell sorting and transplanted them into lethally-irradiated old recipients to generate Sca- ... Methods and Results: We reconstituted old mice with BM cells from young or old GFP+ mice to generate young chimeras and old ...
  http://circ.ahajournals.org/content/132/Suppl_3/A12299
*  Stem Cells and Cloning: Advances and Applications | Volume 8 - Dove Press
 Areas of interest will be established and emerging concepts in stem cell research.Indexed on:American Chemical Society's ... Cardiac tissue engineering and regeneration using cell-based therapy Alrefai MT, Murali D, Paul A, Ridwan KM, Connell JM, Shum- ... Human adipose stem cell and ASC-derived cardiac progenitor cellular therapy improves outcomes in a murine model of myocardial ... Mesenchymal stem cell therapy for osteoarthritis: current perspectives Wyles CC, Houdek MT, Behfar A, Sierra RJ ...
  https://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-archive26-v880
*  Find Research Outputs - Johns Hopkins University
Cell- and Tissue-Based Therapy Anatomy Skeletal Muscle Bridging the gap for lipid lowering therapy: plaque regression, coronary ... The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" ( ... Cardiovascular imaging environment: will the future be cloud-based?. Kawel-Boehm, N. & Bluemke, D. A. Jul 3 2017 In : Expert ... Expert Review of Cardiovascular Therapy. 15, 7, p. 547-558 12 p.. Research output: Research - peer-review › Review article ...
  https://jhu.pure.elsevier.com/en/publications/?showAdvanced=false&allConcepts=true&inferConcepts=true&publicationYear=2013&publicationYear=2014&publicationYear=2015&publicationYear=2016&publicationYear=2017&author=e16fbb3e-f132-4604-94d3-d26e9ad9f1bf
*  Vital Pulp Therapy-Current Progress of Dental Pulp Regeneration and Revascularization
3.2.1. Stem-Cell-Based Tissue Engineering of Dental Pulp. The concept of "tissue engineering" was conceived by Langer and ... Cell Source. The most promising cell sources for tissue engineering are stem cells. A stem cell is an undifferentiated cell, ... ES cells) and postnatal or adult stem cells (AS cells).. Embryonic stem cells are stem cells derived from the inner cell mass ... AS cells are the self-renewable progenitor cells residing within most differentiated tissues and organs. AS cells are thought ...
  https://www.hindawi.com/journals/ijd/2010/856087/
*  Stem cell research
Advances In Stem Cell ResearchResearch Submitted By: M.Z.Arifeen.Submitted By: M.Z.Arifeen. Submitted To: Dr. Aftab Ali Shah… ... as embryonic stem cells do. This may make them potentially useful sources of transplant tissue and cell-based therapies. ... goblet cells, paneth cells, and enteroendocrineabsorptive cells, goblet cells, paneth cells, and enteroendocrine cells.cells.  ... cells and tissues forpotential application of stem cells is making cells and tissues for medical therapiesmedical therapies  ...
  https://www.slideshare.net/zainbbt/stem-cell-research-32258236
*  unesco center - Department of Biotechnology - TechyLib
Cell and tissue based therapies. etc.. 9. E. E. x. x. t. t. r. r. a. a. m. m. u. u. r. r. a. a. l. l. P. P. a. a. r. r. t. t. n ... Translational Health Science and Technology Institute (THSTI), GMP units for cell based. therapy and vaccine. will be made. The ... Tissue E. ngineering,. . Clinical. P. harmacology and. P. harmacogenomics,. . Molecula. r. Metabolism and N. utrition,. . ... Cell biology. . Bioinformatics. . Bio. -. organic Chemistry. . Pharmaceutical Biotechnology. . Bioengineering & Material ...
  https://www.techylib.com/el/view/dactylonomyskittles/unesco_center_department_of_biotechnology
*  Origins of postnatal cardiomyogenesis in the adult mous | Open-i
Stem Cells/cytology*. Minor. *Animals. *Cell- and Tissue-Based Therapy. *Cells, Cultured ... Only αSA+ cells were examined (Fig 7A), in order to assure the purity of the GFP− fraction, and to avoid confounding results ... Only αSA+ cells were examined (Fig 7A), in order to assure the purity of the GFP− fraction, and to avoid confounding results ... Only αSA+ cells were examined.B, C. Flow cytometric analysis of GFP+/αSA+ and GFP−/αSA+ cardiomyocytes for BrdU incorporation ...
  https://openi.nlm.nih.gov/detailedresult.php?img=PMC3569637_emmm0005-0191-f7&req=4
*  Regeneration in humans - Wikipedia
Kabu, S.; Gao, Y.; Kwon, B.K.; Labhasetwar, V. (2015). "Drug delivery, cell-based therapies, and tissue engineering approaches ... In humans with non-injured tissues, the tissue is naturally regenerated over time; by default these tissues have new cells ... 2014). "Humans iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration". ... It has been shown that bone marrow-derived cells could be the source of progenitor cells of multiple cell lineages, and a 2004 ...
  https://en.wikipedia.org/wiki/Regeneration_in_humans
*  'Stem-cell tourism' needs tighter controls, say medical experts |...
... tourism involving patients who travel to developing countries for treatment with unproven and potentially risky therapies ... controls on advertising and agree international standards for the manufacture and testing of cell and tissue-based therapies. ... "Stem cell therapies hold a lot of promise, but we need rigorous clinical trials and regulatory processes to determine whether a ... Some types of stem cell transplant - mainly using blood and skin stem cells - have been approved by regulators after full ...
  https://in.reuters.com/article/health-stemcells-tourism-idINKBN19Q2KX
*  French Regulators Set Up Dedicated Unit for Overseeing Early Stage Clinical Trials | RAPS
ANSM notes that the unit will not oversee studies of other products such as cell and gene therapies, human cell and tissue- ... Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the ... based products, vaccines or medical devices.. The unit will handle all procedures relating to such studies for national ... it will update its Notice to Applicants of Clinical Trials on Medicinal Products Including Clinical Trials on Advanced Therapy ...
  https://www.raps.org/regulatory-focus%E2%84%A2/news-articles/2017/12/french-regulators-set-up-dedicated-unit-for-overseeing-early-stage-clinical-trials
*  US20100015705A1 - Generation of Clonal Mesenchymal Progenitors and Mesenchymal Stem Cell Lines Under Serum-Free Conditions ...
Methods for obtaining multipotent mesenchymal stem cells under serum-free conditions and methods for identifying multipotent ... "Multilineage cells from human adipose tissue: implications for cell-based therapies," Tissue Eng. 7:211-228 (2001); and Young H ... Tissues; Cultivation or maintenance thereof; Culture media therefor * C12N5/06-Animal cells or tissues; Human cells or tissues ... As used herein, "clonal" means a population of cells cultured from a single cell, not from an aggregate of cells. Cells in a " ...
  https://patents.google.com/patent/US20100015705A1/en
*  BioLife Solutions Announces Record Revenue of $2.3 Million in the Second Quart... ( BOTHELL Wash. Aug. 12 2013 /- S...)
... cryopreservation freeze media products are being used in more than fifty clinical trial-stage cell and tissue-based therapies. ... The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of ... BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference. 7. BioLife Solutions ... BioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions for cells, tissues, and ...
  http://bio-medicine.org/biology-technology-1/BioLife-Solutions-Announces-Record-Revenue-of--242-3-Million-in-the-Second-Quarter-of-2013-27254-1/
*  BioLife Solutions Announces Record Revenue and Receipt ... ( Internal Manufacturing Scale-Up Under...)
The regulatory environment surrounding cell and tissue based clinical therapies is becoming more stringent, which makes our ... and commercial companies involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology ... BioLife Solutions Expands Presence in Cell Therapy and Cord Blood Banking Market Segments. 3. As States Cash Flow Crisis Looms ... BioLife Solutions will be presenting and exhibiting at the Phacilitate Cell & Gene Therapy Forum 2009, January 26-28 in ...
  http://www.bio-medicine.org/medicine-news-1/BioLife-Solutions-Announces-Record-Revenue-and-Receipt-of-Funding-34716-1/
*  Adaptimmune Announces Commercial Development and Supply Agreement for Thermo Fisher Scientific's Dynabeads™ CD3/CD28 Cell...
... a leader in T-cell therapy to treat cancer, today announced that it has entered into a commercial development and supply ... For research use or manufacturing of cell, gene, or tissue-based products. Caution: Not intended for direct administration into ... Adaptimmune's lead program is a SPEAR T-cell therapy targeting the NY-ESO cancer antigen. Its NY-ESO SPEAR T-cell therapy has ... to target and destroy cancer cells by strengthening a patient's natural T-cell response. T-cells are a type of white blood cell ...
  https://www.cnbc.com/2016/06/21/globe-newswire-adaptimmune-announces-commercial-development-and-supply-agreement-for-thermo-fisher-scientificas-dynabeadsa-cd3cd28-cell.html